Brief: Sharps Technology CEO Issues Letter To Shareholders On FDA Actions And Tariffs Affecting Chinese Syringes
28/05/2024 18:05
May 28 (Reuters) - Sharps Technology Inc STSS.O :
* SHARPS TECHNOLOGY: CEO ISSUES LETTER TO SHAREHOLDERS ON
FDA
ACTIONS AND TARIFFS AFFECTING CHINESE SYRINGES
* SHARPS TECHNOLOGY INC: EXPERIENCING HEIGHTENED INTEREST IN
OUR
SYRINGE PRODUCTS
* SHARPS TECHNOLOGY INC: PLAN TO BOLSTER OUR MANUFACTURING
CAPABILITIES WITH ADDITION OF A US FACILITY IN NEAR TERM
Source text for Eikon: ID:nGNXc56bx0
Further company coverage: STSS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skyai
See all newsBrief: Bastion Trading Asks Skyai Executive Chairman & Directors "Explain Their Roles" In Approving Complete Sol Liquidation & Tender Offer
Brief: SkyAI Formed Special Committee To Review All-Stock Proposal From Forward Industries - SEC Filing
Brief: Forward Industries Says SkyAI Did Not Respond To Proposal By Its Expiration At Close Of Business On June 12
Brief: SkyAI Confirms Receipt Of Unsolicited, Non-Binding Proposal From Forward Industries
Brief: Forward Industries Announces Letter Of Intent To Acquire Skyai, Inc